Picture1.png
Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner
27. April 2023 07:00 ET | Autolus Therapeutics plc
Cardinal Health to provide core distribution capabilities required for U.S. commercialization of CAR T-cell therapiesInnovative Depot Model intended to reduce delivery time by allowing for transit...